Royalty Pharma PLC (RPRX)

Last Closing Price: 36.37 (2025-07-03)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Royalty Pharma PLC (RPRX) had Net Income of $238.35M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$568.25M
Net Income
$238.35M
--
$568.25M
$34.06M
$534.18M
$-100.75M
$433.43M
$437.71M
$433.43M
$433.43M
$433.43M
$437.71M
$534.18M
$539.46M
435.48M
578.10M
$0.55
$0.55
Balance Sheet Financials
$1.84B
$15.03B
$15.77B
$17.61B
$1.18B
$6.62B
$6.64B
$7.82B
$9.79B
$9.79B
$9.79B
961.02M
Cash Flow Statement Financials
$596.08M
$503.92M
$-941.30M
$929.03M
$1.09B
$158.69M
$0.52M
$-233.81M
--
Fundamental Metrics & Ratios
1.56
--
--
0.40
0.78
100.00%
94.01%
94.01%
--
76.28%
41.94%
$595.02M
--
--
--
0.03
--
23.89
3.77
4.43%
4.43%
2.46%
2.64%
$10.19
$1.03
$1.03